BACKGROUND: Worldwide, approximately 90% of all human immunodeficiency virus (HIV) transmissions occur mucosally; almost all involve R5 strains. Risks of sexual HIV acquisition are highest for rectal, then vaginal, and finally oral exposures. METHODS: Mucosal lacerations may affect the rank order of susceptibility to HIV but cannot be assessed in humans. We measured relative virus transmissibility across intact mucosae in macaques using a single stock of SHIV-1157ipd3N4, a simian-human immunodeficiency virus encoding a primary R5 HIV clade C env (SHIV-C). RESULTS: The penetrability of rhesus macaque mucosae differed significantly, with rectal challenge requiring the least virus, followed by vaginal and then oral routes (P = .031, oral vs vaginal; P < .001 rectal vs vaginal). These findings imply that intrinsic mucosal properties are responsible for the differential mucosal permeability. The latter paralleled the rank order reported for humans, with relative risk estimates within the range of epidemiological human studies. To test whether inflammation facilitates virus transmission--as predicted from human studies--we established a macaque model of localized buccal inflammation. Systemic infection occurred across inflamed but not normal buccal mucosa. CONCLUSION: Our primate data recapitulate virus transmission risks observed in humans, thus establishing R5 SHIV-1157ipd3N4 in macaques as a robust model system to study cofactors involved in human mucosal HIV transmission and its prevention.
BACKGROUND: Worldwide, approximately 90% of all human immunodeficiency virus (HIV) transmissions occur mucosally; almost all involve R5 strains. Risks of sexual HIV acquisition are highest for rectal, then vaginal, and finally oral exposures. METHODS: Mucosal lacerations may affect the rank order of susceptibility to HIV but cannot be assessed in humans. We measured relative virus transmissibility across intact mucosae in macaques using a single stock of SHIV-1157ipd3N4, a simian-human immunodeficiency virus encoding a primary R5 HIV clade C env (SHIV-C). RESULTS: The penetrability of rhesus macaque mucosae differed significantly, with rectal challenge requiring the least virus, followed by vaginal and then oral routes (P = .031, oral vs vaginal; P < .001 rectal vs vaginal). These findings imply that intrinsic mucosal properties are responsible for the differential mucosal permeability. The latter paralleled the rank order reported for humans, with relative risk estimates within the range of epidemiological human studies. To test whether inflammation facilitates virus transmission--as predicted from human studies--we established a macaque model of localized buccal inflammation. Systemic infection occurred across inflamed but not normal buccal mucosa. CONCLUSION: Our primate data recapitulate virus transmission risks observed in humans, thus establishing R5 SHIV-1157ipd3N4 in macaques as a robust model system to study cofactors involved in humanmucosal HIV transmission and its prevention.
Authors: K Page-Shafer; P J Veugelers; A R Moss; S Strathdee; J M Kaldor; G J van Griensven Journal: Am J Epidemiol Date: 1997-10-01 Impact factor: 4.897
Authors: W M Bogers; R Dubbes; P ten Haaft; H Niphuis; C Cheng-Mayer; C Stahl-Hennig; G Hunsmann; T Kuwata; M Hayami; S Jones; S Ranjbar; N Almond; J Stott; B Rosenwirth; J L Heeney Journal: Virology Date: 1997-09-15 Impact factor: 3.616
Authors: A M Trichel; E D Roberts; L A Wilson; L N Martin; R M Ruprecht; M Murphey-Corb Journal: J Med Primatol Date: 1997 Feb-Apr Impact factor: 0.667
Authors: K K Van Rompay; C J Berardi; S Dillard-Telm; R P Tarara; D R Canfield; C R Valverde; D C Montefiori; K S Cole; R C Montelaro; C J Miller; M L Marthas Journal: J Infect Dis Date: 1998-05 Impact factor: 5.226
Authors: G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford Journal: J Virol Date: 2015-04-01 Impact factor: 5.103
Authors: Ivona Pandrea; Nicholas F Parrish; Kevin Raehtz; Thaidra Gaufin; Hannah J Barbian; Dongzhu Ma; Jan Kristoff; Rajeev Gautam; Fang Zhong; George S Haret-Richter; Anita Trichel; George M Shaw; Beatrice H Hahn; Cristian Apetrei Journal: J Virol Date: 2012-02-08 Impact factor: 5.103
Authors: Nagadenahalli B Siddappa; Girish Hemashettar; Yin Ling Wong; Samir Lakhashe; Robert A Rasmussen; Jennifer D Watkins; Francis J Novembre; François Villinger; James G Else; David C Montefiori; Ruth M Ruprecht Journal: J Med Primatol Date: 2010-11-02 Impact factor: 0.667
Authors: Lianna F Wood; Bryan P Brown; Katie Lennard; Ulas Karaoz; Enock Havyarimana; Jo-Ann S Passmore; Anneke C Hesseling; Paul T Edlefsen; Louise Kuhn; Nicola Mulder; Eoin L Brodie; Donald L Sodora; Heather B Jaspan Journal: Clin Infect Dis Date: 2018-09-28 Impact factor: 9.079
Authors: Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson Journal: AIDS Date: 2012-07-31 Impact factor: 4.177
Authors: Mingkui Zhou; Michael Humbert; Muhammad M Mukhtar; Hanna B Scinto; Hemant K Vyas; Samir K Lakhashe; Siddappa N Byrareddy; Gregor Maurer; Swati Thorat; Joshua Owuor; Zhao Lai; Yidong Chen; Anthony Griffiths; Agnès-Laurence Chenine; Sanjeev Gumber; François Villinger; David Montefiori; Ruth M Ruprecht Journal: J Virol Date: 2019-04-17 Impact factor: 5.103
Authors: Nagadenahalli B Siddappa; Jennifer D Watkins; Klemens J Wassermann; Ruijiang Song; Wendy Wang; Victor G Kramer; Samir Lakhashe; Michael Santosuosso; Mark C Poznansky; Francis J Novembre; François Villinger; James G Else; David C Montefiori; Robert A Rasmussen; Ruth M Ruprecht Journal: PLoS One Date: 2010-07-21 Impact factor: 3.240